Lisinopril
- Product NDC
- 43063-814
- 11-digit product format
- 430630814
- Labeler code
- 43063
- Product ID
- 43063-814_415b9940-77ea-a174-e063-6294a90a4cfe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA075743
- Marketing category
- ANDA
- Marketing start
- 2017-08-30
- Substance
- LISINOPRIL
- Active strength
- 30 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lisinopril
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LISINOPRIL | 30 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7199S1YWR |
| Rxcui | 197884, 205326, 311353, 311354, 314076, 314077 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43063-814-01 | Lisinopril | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | | 25 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-814 | LISINOPRIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 24 | Current NDC, Legacy NDC, 1 package rows | 20241017_b62815f3-77fc-4074-a28a-918ab5cc32db.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-814-01 | 43063081401 | 100 TABLET in 1 BOTTLE, PLASTIC (43063-814-01) | 100 tablet | 2018-01-05 | 0000-00-00 | No | No | Current |